IDEXX Laboratories Net Worth

IDEXX Laboratories Net Worth Analysis

IDEXX Laboratories Target Price Consensus

IDEXX Laboratories Target Price Projection

IDEXX Laboratories' current and average target prices are 422.15 and 478.62, respectively. The current price of IDEXX Laboratories is the price at which IDEXX Laboratories is currently trading. On the other hand, IDEXX Laboratories' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on IDEXX Laboratories and the information provided on this page.

Know IDEXX Laboratories' Top Institutional Investors

Note, although IDEXX Laboratories' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow IDEXX Laboratories' market capitalization trends

The company currently falls under 'Large-Cap' category with a current market capitalization of 34.12 B.

Project IDEXX Laboratories' profitablity

The company has Profit Margin (PM) of 0.23 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.27 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.27.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate IDEXX Laboratories' management efficiency

IDEXX Laboratories has return on total asset (ROA) of 0.2269 % which means that it generated a profit of $0.2269 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.5766 %, meaning that it created $0.5766 on every $100 dollars invested by stockholders. IDEXX Laboratories' management efficiency ratios could be used to measure how well IDEXX Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At this time, IDEXX Laboratories' Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to rise to 0.28 in 2025, whereas Return On Capital Employed is likely to drop 0.26 in 2025. At this time, IDEXX Laboratories' Return On Assets are fairly stable compared to the past year.

IDEXX Laboratories Corporate Filings

IDEXX Laboratories time-series forecasting models is one of many IDEXX Laboratories' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary IDEXX Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

IDEXX Laboratories Earnings Estimation Breakdown

The calculation of IDEXX Laboratories' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of IDEXX Laboratories is estimated to be 2.853 with the future projection ranging from a low of 2.77 to a high of 2.96. Please be aware that this consensus of annual earnings estimates for IDEXX Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.

IDEXX Laboratories Earnings Projection Consensus

IDEXX Laboratories Earnings History

Earnings estimate consensus by IDEXX Laboratories analysts from Wall Street is used by the market to judge IDEXX Laboratories' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only IDEXX Laboratories' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods. At this time, IDEXX Laboratories' Retained Earnings are fairly stable compared to the past year. Retained Earnings Total Equity is likely to rise to about 4.3 B in 2025, whereas Price Earnings Ratio is likely to drop 23.63 in 2025. Common Stock Shares Outstanding is likely to rise to about 94.1 M in 2025. Net Income Applicable To Common Shares is likely to rise to about 820 M in 2025.

Hype Prediction Low Estimated High 419.08 421.17 423.26 Details

Intrinsic Valuation Low Real High 408.19 410.28 464.37 Details

Naive Forecast Low Next High 427.44 429.53 431.61 Details

14 Analysts Consensus Low Target High 435.55 478.62 531.27 Details

Note that many institutional investors and large investment bankers can move markets due to the volume of IDEXX assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards IDEXX Laboratories. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving IDEXX Laboratories' stock price in the short term.

IDEXX Laboratories Earnings per Share Projection vs Actual

Actual Earning per Share of IDEXX Laboratories refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering IDEXX Laboratories predict the company's earnings will be in the future. The higher the earnings per share of IDEXX Laboratories, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

IDEXX Laboratories Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as IDEXX Laboratories, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of IDEXX Laboratories should always be considered in relation to other companies to make a more educated investment decision.

IDEXX Quarterly Analyst Estimates and Surprise Metrics

IDEXX Laboratories Corporate Management

Additional Tools for IDEXX Stock Analysis